Last reviewed · How we verify

NCT06911736: POTHeR

Effect of the Postoperative Trendelenburg Position on Chronic Subdural Hematoma Recurrence

Recruiting now NA Last updated 22 April 2025
What this trial tests

NA trial testing Trendelenburg position in Chronic Subdural Hematoma in 254 participants. Currently enrolling.

Timeline
1 June 2024
Primary endpoint
28 February 2025
30 April 2027

Quick facts

Lead sponsorUniversidad de Antioquia
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment254
Start date1 June 2024
Primary completion28 February 2025
Estimated completion30 April 2027
Sites3 locations across Colombia

Drugs / interventions tested

Conditions studied

Sponsor

Universidad de Antioquia — full company profile →

Who can join

18 and older, any sex, with Chronic Subdural Hematoma or Trendelenburg. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective: Determine the effect of the postoperative trendelenburg position on the recurrence of chronic subdural hematoma (CSH) in patients undergoing surgery. Materials and Methods: An open-label, randomized, controlled clinical trial was conducted in three hospitals in Medellín. Patients with CSH were enrolled and assigned to the trendelenburg position (30° leg elevation and 10° head tilt) or a flat bed for 24 hours postoperatively. CSH recurrence was measured at 3 months, along with functional outcome (modified Rankin scale), adverse events, and comfort (Likert scale).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Trendelenburg position

Trials testing the same drug.

Other recruiting trials for Chronic Subdural Hematoma

Currently open trials in the same condition.

Other Universidad de Antioquia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06911736.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing